Synonym:
(±)-N-Methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride,
Fluoxetine hydrochloride,
LY-110,140 hydrochloride,
Prozac®
Properties:
| Related Categories |
Additional Standards,
Analytical Standards,
Analytical/Chromatography,
Chromatography,
Pharmaceutical Secondary Standards,
|
|
grade
|
certified reference material
|
|
|
pharmaceutical secondary standard
|
|
InChI Key
|
GIYXAJPCNFJEHY-UHFFFAOYSA-N
|
|
form
|
neat
|
|
format
|
neat
|
|
pharmacopeia traceability
|
traceable to BP 797
|
|
|
traceable to PhEur F0253000
|
|
|
traceable to USP 1279804
|
Description:
Biochem/physiol Actions
Selective serotonin reuptake inhibitor; antidepressant.
General description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Legal Information
Sold under license from Eli Lilly and Company.
Prozac is a registered trademark of Eli Lilly and Co.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAA1901 in the slot below. This is an example certificate only and may not be the lot that you receive.
Safety:
Hazard statements
H302 + H332-H315-H318-H336-H373-H410
Precautionary statements
P260-P280-P301 + P312 + P330-P305 + P351 + P338 + P310